For individuals facing Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a devastating condition, the emergence of this treatment and the formulated version represents a genuine breakthrough . These novel therapies protect the transthyretin protein, halting its harmful build-up and alleviating the